Ποια είναι η τιμή για Mouwasat Medical Services Company (4002)

Η τιμή για Mouwasat Medical Services Company (4002) είναι $17.29

Ποια είναι η κεφαλαιοποίηση αγοράς για Mouwasat Medical Services Company (4002)

Η κεφαλαιοποίηση αγοράς για Mouwasat Medical Services Company (4002) είναι $3.46B

Mouwasat Medical Services Company (4002) Τιμή και Κεφαλαιοποίηση Αγοράς

Mouwasat Medical Services Company, established in 1974 and headquartered in Dammam, Saudi Arabia, is a prominent healthcare provider. The company's core activities involve the acquisition, management, and operation of a wide array of medical facilities, including hospitals, clinics, pharmacies, and drugstores throughout the Kingdom of Saudi Arabia. Mouwasat operates an extensive chain of hospitals located in key cities such as Dammam, Jubail, Madinah, Khobar, Qatif, and Riyadh, delivering comprehensive medical care to its patients. Beyond general hospital services, the company features specialized centers addressing various health needs. These include dedicated skin care facilities offering cosmetic dermatology, laser treatments, reconstructive and plastic surgery, beauty services, and weight loss programs. It also provides a fertility center and a specialized clinic for bariatric surgery. Further expanding its specialized offerings, Mouwasat boasts a cardiology center for the diagnosis and treatment of heart conditions, a dedicated stroke unit, and a facility focused on managing diabetes and diabetic foot complications. The company also extends its services to include long-term care and rehabilitation. Additionally, Mouwasat Medical Services Company is active in the wholesale distribution of medical equipment and pharmaceutical products.

Η τιμή για 4002	Το περιουσιακό στοιχείο B	Η κεφαλαιοποίηση αγοράς του B	Αποτελέσματα
$25,439.32 $3.46B	NVDA	$5.088T	+147,016.33%
$23,145.44 $3.46B	AAPL	$4.629T	+133,750.75%
$20,587.95 $3.46B	GOOG	$4.118T	+118,960.74%
$18,433.56 $3.46B	MSFT	$3.687T	+106,501.81%
$13,998.21 $3.46B	AMZN	$2.800T	+80,852.09%

Η τιμή για 4002

Το περιουσιακό στοιχείο B

Η κεφαλαιοποίηση αγοράς του B

Αποτελέσματα

$25,439.32 $3.46B